RUPP RANDALL 4
4 · REGENERON PHARMACEUTICALS INC · Filed Oct 18, 2004
Insider Transaction Report
Form 4
RUPP RANDALL
SVP, Manuf & Process Sciences
Transactions
- Sale
Common Stock
2004-10-14$7.33/sh−10,000$73,270→ 11,391 total - Exercise/Conversion
Common Stock
2004-10-14$4.25/sh+10,000$42,500→ 21,391 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2004-10-14−10,000→ 10,000 totalExercise: $4.25Exp: 2004-10-17→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]An exercise date, exercise price, puchase price, sales price and expiration date are not applicable in this case.